Day: September 11, 2023

MISSISSAUGA, Ontario, Sept. 11, 2023 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (“Next Hydrogen”) (TSXV:NXH, OTC:NXHSF) and Casale SA (“Casale”), have signed a non-exclusive memorandum of understanding to develop green ammonia and methanol systems that integrate Next Hydrogen’s electrolysis technology and products. Under this agreement, the companies will bring together their collective experience and capabilities to accelerate and scale-up green ammonia and methanol plants connected to renewable energy sources. Next Hydrogen has deep expertise in electrolysis and is launching its next generation of large-scale, low-cost green hydrogen systems. Casale has a strong track record of technologies innovation in fertilizer production processes and plants, and is ideally positioned to exploit the advantages of Next Hydrogen’s new...

Valentin Curt, MDSenior Vice President, Clinical Drug Development and Interim Chief Medical Officer at Eagle Pharmaceuticals— CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an infectious pathogen’s virulence factors to reduce damage and mitigate disease —— The first-in-human study showed positive safety and efficacy when added to standard of care in patients with severe community-acquired bacterial pneumonia —WOODCLIFF LAKE, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that its abstract describing the global in-progress Phase 2 study of CAL02, a first-in-class, broad-spectrum, anti-virulence agent under development as an adjunct to antibiotic therapy for...

MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting virtually at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th. The webcast to this presentation will be available here at 7am Eastern Daylight Time / 9pm Australian Eastern Standard time on September 11th. A copy of the presentation being made at the H.C. Wainwright 25th Annual Global Investment Conference is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ This release has been authorised by the directors of Immuron Limited. COMPANY CONTACT: Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com   About...

Amsterdam/’s-Hertogenbosch, the Netherlands, 11 September 2023 Van Lanschot Kempen has given a notice of meeting for the purpose of soliciting a consent for the transfer of the outstanding covered bonds under its €5 billion Conditional Pass-Through Covered Bond programme to its €5 billion Soft Bullet Covered Bond programme. Proposed amendmentsThe purpose of the consent solicitation is that all the outstanding series under the Conditional Pass-Through Covered Bond programme will be consolidated into the Soft Bullet Covered Bond programme. After implementation, the proposed amendments will result in replacing the guarantor of the Conditional Pass-Through Covered Bond programme with the guarantor of the Soft Bullet Covered Bond programme and to modify and/or replace the final terms and the conditions of the Conditional Pass-Through Covered...